Clinical trial
Augmenting Exposure Therapy With an N-Methyl-D-Aspartate (NMDA) Agonist for…
NCT00131339 · Hartford Hospital, Other · Completed
Key facts
| NCT number | NCT00131339 |
|---|---|
| Title | Augmenting Exposure Therapy With an N-Methyl-D-Aspartate (NMDA) Agonist for Panic Disorder |
| Official title | Placebo-Controlled Evaluation of the Efficacy of D-Cycloserine for Enhancing the Effects of CBT for Panic Disorder |
| Lead sponsor | Hartford Hospital, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Panic Disorder |
| Intervention type | Behavioral, Drug |
| Interventions | Cognitive behavioral therapy, D-cycloserine |
| Enrollment | 40 |
| Start date | Nov 1, 2004 |
| Completion | Mar 1, 2007 |
| First posted | Aug 18, 2005 |
| Last update posted | Aug 26, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: